S. Wilde

发表

Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

Tongguang Wang, Dolores J. Schendel, Richard A. Morgan, 2013, Journal of immunotherapy.

The CD6 Scavenger Receptor Is Differentially Expressed on a CD56dim Natural Killer Cell Subpopulation and Contributes to Natural Killer-Derived Cytokine and Chemokine Secretion

J. Ellwart, L. Umansky, C. Falk, 2010, Journal of Innate Immunity.

T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity

E. Noessner, D. Sommermeyer, M. Salvermoser, 2022, Cancers.

Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy.

G. Willimsky, W. Uckert, M. Leisegang, 2017, Cancer research.

Inhibitory Effect of RNA Pool Complexity on Stimulatory Capacity of RNA-pulsed Dendritic Cells

E. Noessner, V. Lennerz, T. Wölfel, 2008, Journal of immunotherapy.

Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells

G. Willimsky, T. Blankenstein, E. Noessner, 2005, World Journal of Urology.

The rate of extrachromosomal homologous recombination within a novel reporter plasmid is elevated in cells lacking functional ATM protein.

J. Ellwart, W. Beisker, F. Eckardt-Schupp, 2004, DNA repair.

Human Antitumor CD8+ T Cells Producing Th1 Polycytokines Show Superior Antigen Sensitivity and Tumor Recognition

W. Uckert, M. Leisegang, D. Sommermeyer, 2012, The Journal of Immunology.

Sensitivity and Tumor Recognition Th1 Polycytokines Show Superior Antigen T Cells Producing + Human Antitumor CD8

W. Uckert, M. Leisegang, D. Sommermeyer, 2012 .

MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors.

W. Uckert, M. Leisegang, S. Wilde, 2010, The Journal of clinical investigation.

Generation of Th1-Polarizing Dendritic Cells Using the TLR7/8 Agonist CL075

S. Tippmer, S. Wilde, Barbara Mosetter, 2010, The Journal of Immunology.

This information is current as Using the TLR 7 / 8 Agonist CL 075 Generation of Th 1-Polarizing Dendritic Cells

S. Tippmer, S. Wilde, Barbara Mosetter, 2010 .

P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma

M. Mann, D. Busch, M. Bassani-Sternberg, 2014, Journal of Immunotherapy for Cancer.

Generation of allo-restricted peptide-specific T cells using RNA-pulsed dendritic cells

S. Wilde, Barbara Mosetter, D. Schendel, 2012, Oncoimmunology.

Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation

S. Wilde, D. Schendel, S. Spranger, 2010, Journal of Translational Medicine.

Production de cellules specifiques d'antigenes

T. Blankenstein, S. Wilde, D. Schendel, 2006 .

High-quality and high-avidity T cell clones specific for tumor-associated antigens and how to find them

S. Wilde, D. Schendel, 2012, Oncoimmunology.

Misinitiation of intrathymic MART‐1 transcription and biased TCR usage explain the high frequency of MART‐1‐specific T cells

B. Kyewski, T. Blankenstein, W. Uckert, 2014, European journal of immunology.

Codon Optimization of the Human Papillomavirus E7 Oncogene Induces a CD8+ T Cell Response to a Cryptic Epitope Not Harbored by Wild-Type E7

W. Uckert, S. Wilde, Barbara Mosetter, 2015, PloS one.

T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.

M. Mann, D. Busch, W. Uckert, 2015, Gastroenterology.

Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity.

D. Busch, W. Uckert, M. Schiemann, 2009, Blood.

Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide–MHC Complexes for T-Cell Receptor Immunotherapy

W. Uckert, S. Wilde, D. Schendel, 2017, Human gene therapy.

TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo.

I. Jeremias, M. Heemskerk, W. Uckert, 2012, Blood.

avidity functional induce T cells with superior antitumor activity and higher TCR Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen

D. Busch, M. Schiemann, D. Sommermeyer, 2013 .

Misinitiation of intrathymic MART‐1 transcription and biased TCR usage explain the high frequency of MART‐1‐specific T cells

B. Kyewski, T. Blankenstein, W. Uckert, 2014, European journal of immunology.